Validation and application of an HPLC-EC method for analysis of coenzyme Q10 in blood platelets

Biomedical Chromatography

Volumn 22, Issue 12, 2008, Pages 1403-1408

  Miles, Michael V ^a   Tang, Peter H ^a   Miles, Lili ^a   Steele, Paul E ^a   Moye, Mark J ^a   Horn, Paul S ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Absorption; Coenzyme Q10; HPLC; Platelet; Ubiquinol; Ubiquinone; Validation

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; COENZYMES;

BLOOD PLATELETS; CALIBRATION CURVES; COENZYME Q10; ELECTROCHEMICALS; HPLC; METHOD ANALYSIS; OXIDIZING POTENTIALS; UBIQUINOL; UBIQUINONE; VALIDATION;

PLATELETS;

ACTIVE Q; UBIDECARENONE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; UBIQUINOL; UBIQUINONE;

ACCURACY; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CENTRIFUGATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYOPRESERVATION; DIET RESTRICTION; DIET SUPPLEMENTATION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; OXIDATION; PREDICTION; SINGLE DRUG DOSE; THROMBOCYTE; VOLUNTEER; BLOOD; CHEMISTRY; METHODOLOGY; REPRODUCIBILITY;

BLOOD PLATELETS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REPRODUCIBILITY OF RESULTS; UBIQUINONE;

EID: 59649122495     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1072     Document Type: Article

References (19)

1. Barshop BA and Gangoiti JA. Analysis of coenzyme Q in human blood and tissues. Mitochondrion 2007; 7 Suppl: S89-S93.
2. Crane FL. Discovery of ubiquinone (coenzyme Q) and an overview of function. Mitochondrion 2007; 7(suppl.): S2-S7.
3. Farooqui AA, Ong WY and Horrocks LA. Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacological Reviews 2006; 58: 591-620.
4. Götz ME, Gerstner A, Harth R, Dirr A, Janetzky B, Kuhn W, Riederer P and Gerlach M. Altered redox state of platelet coenzyme Q10 in Parkinson's disease. Journal of Neural Transmission 2000; 107: 41-48.
5. Hara K, Yamashita S, Fujisawa A, Ishiwa S, Ogawa T and Yamamoto Y. Oxidative stress in newborn infants with and without asphyxia as measured by plasma antioxidants and free fatty acids. Biochemical and Biophysical Research Communications 1999; 257: 244-248.
6. Hatefi Y. Coenzyme Q (ubiquinone). Advances in Enzymology and Related Areas of Molecular Biology 1963; 25: 275-328.
7. Merlo Pich M, Castagnoli A, Biondi A, Bernacchia A, Tazzari PL, D'Aurelio M, Parenti Castelli G, Formiggini G, Conte R, Bovina C and Lenaz G. Ubiquinol and a coenzyme Q reducing system protect platelet mitochondrial function of transfusional buffy coats from oxidative stress. Free Radical Research 2002; 36: 429-436.
8. Miles L, Miles MV, Tang PH, Horn PS, Wong B, DeGrauw T, Morehart P and Bove KE. Coenzyme Q: a potential marker for mitochondrial activity and redox status in skeletal muscle. Pediatric Neurology 2005; 32: 318-324.
9. Miles MV, Patterson BJ, Chalfonte-Evans M, Horn PS, Hickey FJ, Schapiro MB, Tang PH, Steele PE and Hotze SL. Ubiquinol-10 improves oxidative imbalance in children with trisomy 21. Pediatric Neurology 2007; 37: 398-403.
10. Molyneux S, Lever M, Florkowski C and George P. Plasma total coenzyme Q9 (CoQ9) in the New Zealand population: reference interval and biological variation. Clinical Chemistry 2007; 53: 802-803.
11. Niklowitz P, Menke T, Wiesel T, Mayatepek E, Zschocke J, Okun JG and Andler W. Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia. Clinica Chimica Acta 2002; 326: 55-61.
12. Niklowitz P, Menke T, Andler W and Okun JG. Simultaneous analysis of coenzyme Q10 in plasma, erythrocytes and platelets: comparison of the antioxidant level in blood cells and their environment in healthy children and after oral supplementation in adults. Clinica Chimica Acta 2004; 342: 219-226.
13. Niklowitz P, Andler W and Menke T. Coenzyme Q10 concentration in plasma and blood cells: what about diurnal changes? Biofactors 2006; 28: 47-54.
14. Niklowitz P, Sonnenschein A, Janetzky B, Andler W and Menke T. Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage. International Journal of Biological Sciences 2007; 3: 257-262.
15. Sohmiya M, Tanaka M, Tak NW, Yanagisawa M, Tanino Y, Suzuki Y, Okamoto K and Yamamoto Y. Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease. Journal of the Neurological Sciences 2004; 223: 161-166.
16. Steele PE, Tang PH, DeGrauw AJ and Miles MV. Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases. American Journal of Clinical Pathology 2004; 121(suppl.): S113-S120.
17. Tang PH, Miles MV, DeGrauw A, Hershey A and Pesce A. HPLC analysis of reduced and oxidized coenzyme Q10 in human plasma. Clinical Chemistry 2001; 47: 256-265.
18. Wada H, Hagiwara S, Saitoh E, Ieki R, Okamura T, Ota T, Iguchi M, Yuasa K, Kodaka T, Koishi T, Yamamoto Y and Goto H. Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) as measured by redox status of plasma coenzyme Q10. Pathophysiology 2006; 13: 29-33.
19. Yamamoto Y, Yamashita S, Fujisawa A, Kokura S and Yoshikawa T. Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants. Biochemical and Biophysical Research Communications 1998; 247: 166-170.